0001683168-19-001345.txt : 20190502 0001683168-19-001345.hdr.sgml : 20190502 20190502173330 ACCESSION NUMBER: 0001683168-19-001345 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190422 FILED AS OF DATE: 20190502 DATE AS OF CHANGE: 20190502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hwang Larn CENTRAL INDEX KEY: 0001697480 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 19793293 MAIL ADDRESS: STREET 1: C/O MARINA BIOTECH, INC. STREET 2: 17870 CASTLETON STREET, SUITE 250 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 3 1 ownership.xml X0206 3 2019-04-22 0 0000908259 MATEON THERAPEUTICS INC MATN 0001697480 Hwang Larn 60 PAINTED TRELLIS IRVINE CA 92620 0 0 1 0 Common Stock 4095581 D Series A Convertible Preferred Stock 2019-04-22 Common Stock 19350411 D Reflects securities of the Issuer acquired by the reporting person pursuant to the Agreement and Plan of Merger, dated April 22, 2019, by and among the Issuer and Oncotelic, Inc. The Series A Convertible Preferred Stock is convertible at the holder's election and has no expiration date. Each share of Series A Convertible Preferred Stock is convertible into one thousand (1,000) shares of Common Stock. /s/ Larn Hwang 2019-05-02